TYVASO® is the FIRST AND ONLY medication approved by the FDA for the treatment of PH-ILD
Ask your doctor about TYVASO to learn more.
Download Patient Brochure
TYVASO is indicated for pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3), which is high blood pressure in the lungs due to inflammation and sometimes scarring in the lungs. TYVASO can improve the ability to exercise.
Sign up to learn more
Receive updates and support from TYVASO.
Thanks for signing up!
You should begin receiving emails soon.